These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 15701587
1. Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation. Vissers WH, Roelofzen J, De Jong EM, Van Erp PE, Van de Kerkhof PC. Eur J Dermatol; 2005; 15(1):13-7. PubMed ID: 15701587 [Abstract] [Full Text] [Related]
2. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. Bovenschen HJ, Seyger MM, Van de Kerkhof PC. Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329 [Abstract] [Full Text] [Related]
3. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC. Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496 [Abstract] [Full Text] [Related]
4. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis. Vissers WH, Berends M, Muys L, van Erp PE, de Jong EM, van de Kerkhof PC. Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104 [Abstract] [Full Text] [Related]
5. Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis. Vissers WH, Muys L, Erp PE, de Jong EM, van de Kerkhof PC. Eur J Dermatol; 2004 Feb; 14(4):216-20. PubMed ID: 15319153 [Abstract] [Full Text] [Related]
6. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. Vissers WH, van Vlijmen I, van Erp PE, de Jong EM, van de Kerkhof PC. Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400 [Abstract] [Full Text] [Related]
7. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study. Bovenschen HJ, Langewouters AM, van de Kerkhof PC. Am J Clin Dermatol; 2010 Apr; 11(5):343-50. PubMed ID: 20553063 [Abstract] [Full Text] [Related]
8. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis. Bovenschen HJ, Gerritsen WJ, van Rens DW, Seyger MM, de Jong EM, van de Kerkhof PC. Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563 [Abstract] [Full Text] [Related]
10. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment. Bovenschen HJ, Vissers WH, Seyger MM, van de Kerkhof PC. Acta Derm Venereol; 2005 Nov; 85(2):113-7. PubMed ID: 15823902 [Abstract] [Full Text] [Related]
11. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis. Liao YH, Jee SH, Sheu BC, Huang YL, Tseng MP, Hsu SM, Tsai TF. Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169 [Abstract] [Full Text] [Related]
12. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM. J Dermatolog Treat; 2007 Aug; 18(1):32-9. PubMed ID: 17365265 [Abstract] [Full Text] [Related]
13. The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol. Vissers WH, van Duijnhoven M, van Erp PE, de Jong EM, van de Kerkhof PC. J Dermatolog Treat; 2008 Aug; 19(6):344-50. PubMed ID: 19016104 [Abstract] [Full Text] [Related]
14. The role of lesional T cells in recalcitrant psoriasis during infliximab therapy. Bovenschen HJ, Van De Kerkhof PC, Gerritsen WJ, Seyger MM. Eur J Dermatol; 2005 Aug; 15(6):454-8. PubMed ID: 16280298 [Abstract] [Full Text] [Related]
15. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity. Horrocks C, Holder JE, Berth-Jones J, Camp RD. Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325 [Abstract] [Full Text] [Related]
16. Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study. Bovenschen HJ, Otero ME, Langewouters AM, van Vlijmen-Willems IM, van Rens DW, Seyger MM, van de Kerkhof PC. Br J Dermatol; 2007 Feb; 156(2):263-70. PubMed ID: 17223865 [Abstract] [Full Text] [Related]
17. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis. Körver JE, van Duijnhoven MW, Pasch MC, van Erp PE, van de Kerkhof PC. Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416 [Abstract] [Full Text] [Related]
18. Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples. Carrascosa JM, Tapia G, Bielsa I, Fuente MJ, Ferrandiz C. J Cutan Pathol; 2007 Oct; 34(10):769-76. PubMed ID: 17880582 [Abstract] [Full Text] [Related]
19. Perforin expression is upregulated in the epidermis of psoriatic lesions. Kastelan M, Prpić Massari L, Gruber F, Zamolo G, Zauhar G, Coklo M, Rukavina D. Br J Dermatol; 2004 Oct; 151(4):831-6. PubMed ID: 15491424 [Abstract] [Full Text] [Related]
20. Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis. Langewouters AM, van Erp PE, de Jong EM, van de Kerkhof PC. Arch Dermatol Res; 2008 Mar; 300(3):107-13. PubMed ID: 18157542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]